HemosIL Silica Clotting Time

FDA 510(k) K253957 · Instrumentation Laboratory (IL) Co.

Substantially Equivalent

510(k) numberK253957

Submission

Device name
HemosIL Silica Clotting Time
Applicant
Instrumentation Laboratory (IL) Co.
Bedford, MA, US
Received
December 10, 2025
Decision date
January 9, 2026
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GFO – Activated Partial Thromboplastin
Device class
Class II (moderate risk)
Regulation
21 CFR 864.7925
Specialty
Hematology

Other 510(k)s with product code GFO

510(k)DeviceApplicantDecision
K193556Cryocheck Hex LAGFO · Traditional Precision Biologic10/23/2020SE
K160445HemosIL Silica Clotting TimeGFO · Special Instrumentation Laboratory CO03/16/2016SE
K053111Sta-Cephascreen KitGFO · Traditional Diagnostica Stago, Inc.05/04/2006SE
K060688Hemosil SynthasilGFO · Special Instrumentation Laboratory CO04/13/2006SE
K050221Hemosil Silica Clotting TimeGFO · Traditional Instrumentation Laboratory CO03/30/2005SE
K022021Vital Scientific Aptt, Aptt & Quikcoag ApttGFO · Traditional Vital Scientific N.V.11/01/2002SE
K014028Careside ApttGFO · Traditional Careside Hemotology, Inc.02/08/2002SE
K014008Hemochron Jr. Citrate Aptt CuvetteGFO · Special Itc, Inc.01/24/2002SE
K992712Sigma Diagnostics Alexin LS, Models A1219, A1334GFO · Traditional Sigma Diagnostics, Inc.12/06/1999SE
K992711Sigma Diagnostics Alexin HS, Models A0969, A1094GFO · Traditional Sigma Diagnostics, Inc.12/06/1999SE

More from Sigma Diagnostics, Inc.

510(k)DeviceDecision
K260551HemosIL Factor V Leiden (APC Resistance V)GGW · Special 03/20/2026SE
K251968HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XLKQJ · Special 07/24/2025SE
K243374HemosIL CL HIT-IgG(PF4-H)LCO · Traditional 01/28/2025SE
K242127ACL TOP Family 50 Series (ACL TOP 750; ACL TOP 750 CTS; ACL TOP 750 LAS; ACL TOP 550…GKP · Special 08/16/2024SE

Questions and answers

When was HemosIL Silica Clotting Time cleared by the FDA?

HemosIL Silica Clotting Time (K253957) received a 510(k) decision of Substantially Equivalent on January 9, 2026, 30 days after the submission was received.

What is the product code of K253957?

The FDA product code is GFO – Activated Partial Thromboplastin, a Class II (moderate risk) device regulated under 21 CFR 864.7925.